Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of 棉花花总黄酮片 in mild to moderate Alzheimer's disease
CTR20210225Phase 2Active
- Sponsor
- Xinjiang Technical Institute of Physics and Chemistry
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cotton flower total flavonoids in Alzheimer's disease (AD), sponsored by Xinjiang Technical Institute of Physics and Chemistry. Started Dec 2021; status: active.
02
Drugs
cotton flower total flavonoids
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on CTR20210225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210225.